SKYRIZI is a biologic that has been prescribed to more than 260,000 patients in the USA. * * Includes adults with: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s disease, and Ulcerative Colitis. Data is sourced from Symphony Health, an ICON plc Company, IDV ® and SKYRIZI Bridge Program data from April 2019 through November 2024.

Understanding the Context

Discover SKYRIZI, an FDA-approved biologic treatment for psoriasis. See full Safety and Prescribing Information. SKYRIZI (Sky-RIZZ-ee; skaɪ rɪz zi), an injection, is known as an interleukin-23 (IL-23) inhibitor. † It works inside your body to treat adults with moderate to severe Ps who can take injections, pills (systemic therapy), or ultraviolet light therapy (phototherapy), and for adults with active PsA.

Key Insights

* A biologic is a type of medication that is derived from living organisms, such as cells ... The SKYRIZI design SKYRIZI works with your immune system, attaching to a specific protein that can cause inflammation. By attaching to this protein, SKYRIZI helps reduce chronic inflammation inside your body that leads to painful, discolored, itchy, burning plaques on the skin. SKYRIZI INFUSIONS SKYRIZI treatment starts with 3 intravenous (IV) infusions: , as prescribed by your doctor. After completing your third infusion, you will start using the SKYRIZI On-Body Injector (OBI) according to Your doctor prescribed SKYRIZI Discover SKYRIZI® (risankizumab-rzaa), a biologic treatment for adults with Active Psoriatic Arthritis (PsA).

Final Thoughts

See Full Safety and Prescribing Information. See SKYRIZI® results for the treatment of psoriasis. SKYRIZI® is an FDA-approved biologic treatment for psoriasis See full Safety and Prescribing Information. Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease. See full Safety and Prescribing Information.